SCHEMBL5655671

SCHEMBL5655671

CCOc1cc(C(O)c2ccccn2)ccc1[N+](=O)[O-]

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.44
ALDH1A1 P00352 5/20 0.43
LMNA P02545 3/20 0.43
MEN1 O00255 2/20 0.42
KMT2A Q03164 2/20 0.42
SMN1; SMN2 Q16637 2/20 0.42
HTT P42858 1/20 0.42
RAB9A P51151 1/20 0.42
NPSR1 Q6W5P4 1/20 0.42
MAPK1 P28482 1/20 0.41
RECQL P46063 1/20 0.41
MAOA P21397 1/20 0.41
F7 P08709 1/20 0.41
CYP11B1 P15538 2/20 0.40
CYP11B2 P19099 2/20 0.40
GAA P10253 1/20 0.39
KDM4E B2RXH2 1/20 0.38
KAT7 O95251 1/20 0.38
KAT6A Q92794 1/20 0.38
RXFP1 Q9HBX9 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5105719 0.80 GAA (0.46) MAPTALDH1A1MEN1KMT2ASMN1; SMN2
SCHEMBL5655478 0.79 ALDH1A1 (0.49) MAPTALDH1A1LMNAMEN1KMT2A
SCHEMBL7369124 0.78 KAT7 (0.45) MAPTALDH1A1LMNAMEN1KMT2A
SCHEMBL5110988 0.77 L3MBTL1 (0.55) MAPTALDH1A1LMNAMEN1KMT2A
SCHEMBL31067521 0.77 SMN1; SMN2 (0.42) MAPTALDH1A1LMNAMEN1KMT2A
SCHEMBL17064620 0.77 SMN1; SMN2 (0.42) MAPTALDH1A1LMNAMEN1KMT2A
SCHEMBL11711222 0.77 SMN1; SMN2 (0.50) MAPTALDH1A1LMNAMEN1KMT2A
SCHEMBL5110743 0.76 F7 (0.44) MAPTALDH1A1MEN1KMT2ASMN1; SMN2
Hydrochloric Acid SCHEMBL11712128 0.76 SMN1; SMN2 (0.49) MAPTALDH1A1LMNAMEN1KMT2A
SCHEMBL12040940 0.76 MAPT (0.55) MAPTALDH1A1LMNAMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7262185-B2 Benzazepine derivative, process for producing the same, and use TAKEDA CHEMICAL INDUSTRIES LTD. (JP) 2007-08-28 US disclosed
US-20040235822-A1 Benzazepine derivative, process for producing the same, and use TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2004-11-25 US disclosed
EP-1422228-A1 BENZAZEPINE DERIVATIVE, PROCESS FOR PRODUCING THE SAME, AND USE Takeda Chemical Industries, Ltd. (JP) 2004-05-26 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040235822-A1 Benzazepine derivative, process for producing the same, and use CYP1B1, CYP1A1, CYP2E1 MAPT 3095/4885ALDH1A1 519/4885LMNA 753/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.